About the Chorioretinitis Session
Chorioretinitis is characterized by inflammation affecting both the choroid (a vascular layer) and the retina (a light-sensitive layer) of the eye. It can result from various infectious agents such as viruses (e.g., cytomegalovirus), bacteria (e.g., toxoplasmosis), fungi (e.g., histoplasmosis), or parasites (e.g., toxocariasis), as well as non-infectious causes like autoimmune diseases such as sarcoidosis. Typical symptoms of chorioretinitis include blurred vision, floaters, and occasionally, loss of peripheral vision. Diagnosis involves a comprehensive eye examination, often incorporating imaging techniques like optical coherence tomography (OCT) and fluorescein angiography to evaluate the extent of inflammation and its impact on retinal structures. Treatment strategies vary depending on the underlying cause and severity but typically include antiviral, antibiotic, or antiparasitic medications, along with corticosteroids to alleviate inflammation. In some instances, laser therapy may be necessary to mitigate complications such as retinal detachment. Timely diagnosis and intervention are critical in managing chorioretinitis effectively and minimizing the risk of permanent vision impairment.
Topics Covered in Chorioretinitis
Toxoplasma Retinochoroiditis
CMV Retinitis
Ocular Toxocariasis
Syphilitic Chorioretinitis
Ocular Sarcoidosis
OCT & Fluorescein Angiography
Related Scientific Sessions at IOC 2027
Why Attend the Chorioretinitis Conference 2027
Earn CPD Credit
Sessions are CPD-accredited by The CPD Group (UK) — one CPD credit for every hour of attendance.
Present Your Research
Oral and poster slots for original Chorioretinitis work, reviewed by the scientific committee.
Network Globally
Meet ophthalmologists, vision scientists, and eye-care clinicians from around the world across three days.
Publish & Get Indexed
Accepted abstracts are compiled into the conference proceedings and indexed in Scopus and Web of Science.
Learn from Keynotes
Plenary lectures from leading voices shaping Chorioretinitis research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join IOC 2027 for the Chorioretinitis track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Chorioretinitis Conference 2027 — FAQs
What is the Chorioretinitis track at IOC 2027?
The Chorioretinitis track is a dedicated stream within IOC 2027 covering the latest research, clinical innovation, and best practice in Chorioretinitis. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Chorioretinitis sessions?
Ophthalmologists, optometrists, vision scientists, educators, doctoral students, and trainees with an interest in Chorioretinitis are all welcome — whether presenting or attending.
Can I present my research in the Chorioretinitis track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Chorioretinitis sessions?
Yes. IOC 2027 is a hybrid conference — attend the Chorioretinitis track in person in Singapore or join live online, with on-demand access afterward.
Join the IOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.
